ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients

Keywords : Patients Breast
Document type :
Journal articles
Complete list of metadatas

https://hal-univ-lyon1.archives-ouvertes.fr/hal-01795705
Contributor : Lauriane Pillet <>
Submitted on : Friday, May 18, 2018 - 4:38:39 PM
Last modification on : Friday, March 8, 2019 - 1:27:36 AM

Links full text

Identifiers

Citation

O. Tredan, C. Menetrier-Caux, I. Ray-Coquard, G. Garin, C. Cropet, et al.. ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients. Annals of Oncology, Oxford University Press (OUP), 2017, ⟨10.1093/annonc/mdx058⟩. ⟨hal-01795705⟩

Share

Metrics

Record views

47